Athletic PerformanceNCT07092735
Neuro-Athletic Training in Football
A study testing Neuro-Athletic Training and Standard Training in people with Athletic Performance and Neurocognitive Function, run by Ankara Yildirim Beyazıt University at 1 site in Turkey (Türkiye).
Trial summary
This randomized controlled trial evaluates the effectiveness of an 8-week neuro-athletic training (NAT) program in enhancing sport-specific skills and physical capacities in elite male football players aged 18-23 years. Read more about this study
- Who is it for?
- Ages 18 to 23 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Athletic Performance, Neurocognitive Function, Proprioception
- What is being tested?
- Neuro-Athletic Training and Standard Training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 56 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 12 Jun 2024to 12 Aug 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 23 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- Male football players aged 18-23 years
- Active in the Turkish Regional Amateur League (2023-2024 season)
- Minimum of 5 years of uninterrupted football training experience
- No known neuromuscular or visual impairments
- Participation in at least four football training sessions per week
- Willingness and ability to participate in all assessments and training sessions
- Provision of written informed consent
Who cannot join
- History of orthopedic or neurological surgery within the past year
- Acute or chronic musculoskeletal injuries preventing full participation
- Uncorrected visual impairment
- Use of medications affecting neuromuscular performance or coordination
- Previous or concurrent involvement in structured neuromuscular or neuro-athletic training programs
- Irregular attendance to training sessions (>20% missed)
- Any condition precluding safe participation, as determined by medical staff
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Optimizing Elite Football Performance Through Neuro-Athletic Training: A Parallel-Group Randomized Controlled Trial
This randomized controlled trial evaluates the effectiveness of an 8-week neuro-athletic training (NAT) program in enhancing sport-specific skills and physical capacities in elite male football players aged 18-23 years. Participants were randomly assigned to a NAT intervention group or a control group that maintained standard training. The NAT program involved oculomotor, vestibular, and proprioceptive drills. Primary outcomes include passing and shooting accuracy; secondary outcomes include flexibility and isokinetic knee strength.
- Conditions
- Athletic Performance, Neurocognitive Function, Proprioception, Soccer, Sensorimotor Integration, Eye Movements
- Being tested
- Neuro-Athletic Training, Standard Training
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neuro-Athletic TrainingBehavioural
Participants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each).
Standard TrainingOther
Participants continue their standard in-season football training program without any NAT components.
| Study group | Role | What they receive |
|---|---|---|
| Neuro-Athletic Training (NAT) Group | Experimental | Participants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each). Receives: Behavioral: Neuro-Athletic Training |
| Standard Training Group | Active comparator | Participants continue their standard in-season football training program without any NAT components. Receives: Other: Standard Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Passing Accuracy (Mor-Christian Passing Test)
Measured as a score (max 120) based on 12 passes from 7, 8.5, and 10 meters toward a mini-goal. Assessed pre- and post-intervention.
Measured: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Shooting Accuracy (Mor-Christian Shooting Test)
Measured as a score (max 80) based on 16 shots from 14.5 meters toward four 45 cm targets. Assessed pre- and post-intervention.
Measured: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Secondary outcomes (2)
Flexibility (Sit-and-Reach Test)
Measured in centimeters using a standard sit-and-reach box, assessing hamstring and lower back flexibility.
Measured: Pre-intervention (baseline) and post-intervention (after 8 weeks)
Isokinetic Knee Strength (ISOMED 2000 Dynamometer)
Concentric peak torque of quadriceps and hamstrings at 60°/s (5 repetitions) and 180°/s (15 repetitions), normalized to body mass (Nm/kg), and hamstring-to-quadriceps (H:Q) ratio.
Measured: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Jul 2025
- Study start12 Jun 2024
- Primary completion12 Jul 2024
- Study completion12 Aug 2024
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Athletic PerformanceStudies of the same condition, open and under way.
- More trials run by Ankara Yildirim Beyazıt UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- This study used a parallel-group randomized controlled trial design with pre- and post-intervention assessments. Participants were randomly assigned to either a Neuro-Athletic Training (NAT) group or a control group. The NAT group received an 8-week structured program targeting sensorimotor integration through oculomotor, vestibular, and proprioceptive drills, while the control group continued standard football training without additional interventions. Outcome assessors and statistical analysts were blinded to group allocations. The study was conducted under standardized conditions to ensure methodological rigor and group comparability.
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Ankara Yildirim Beyazıt University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07092735
- Sponsor's protocol ID
- 2024/71
- Status last verified
- Jul 2025
- First submitted
- 9 Jul 2025
- Last updated
- 30 Jul 2025
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data (IPD) will not be shared due to privacy concerns and institutional data protection policies.
Study at a glance
From the registry record, last updated by the sponsor on 30 Jul 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Optimizing Elite Football Performance Through Neuro-Athletic Training: A Parallel-Group Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07092735
- Acronym / sponsor ID
- 2024/71
- Conditions
- Athletic Performance, Neurocognitive Function, Proprioception, Soccer, Sensorimotor Integration, Eye Movements
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Ankara Yildirim Beyazıt UniversityUniversity, hospital or other
- Study start
- 12 Jun 2024 (actual)
- Primary completion
- 12 Jul 2024 (actual)
- Study completion
- 12 Aug 2024 (actual)
- First posted
- 30 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This randomized controlled trial evaluates the effectiveness of an 8-week neuro-athletic training (NAT) program in enhancing sport-specific skills and physical capacities in elite male football players aged 18-23 years. Participants were randomly assigned to a NAT intervention group or a control group that maintained standard training. The NAT program involved oculomotor, vestibular, and proprioceptive drills. Primary outcomes include passing and shooting accuracy; secondary outcomes include flexibility and isokinetic knee strength.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
- Model description
- This study used a parallel-group randomized controlled trial design with pre- and post-intervention assessments. Participants were randomly assigned to either a Neuro-Athletic Training (NAT) group or a control group. The NAT group received an 8-week structured program targeting sensorimotor integration through oculomotor, vestibular, and proprioceptive drills, while the control group continued standard football training without additional interventions. Outcome assessors and statistical analysts were blinded to group allocations. The study was conducted under standardized conditions to ensure methodological rigor and group comparability.
| Arm | Type | Receives |
|---|---|---|
| Neuro-Athletic Training (NAT) Group | Experimental | Behavioral: Neuro-Athletic TrainingParticipants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each). |
| Standard Training Group | Active comparator | Other: Standard TrainingParticipants continue their standard in-season football training program without any NAT components. |
Who may qualify
- Ages
- 18 to 23 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- Male football players aged 18-23 years
- Active in the Turkish Regional Amateur League (2023-2024 season)
- Minimum of 5 years of uninterrupted football training experience
- No known neuromuscular or visual impairments
- Participation in at least four football training sessions per week
Key exclusion criteria (7 listed)
- History of orthopedic or neurological surgery within the past year
- Acute or chronic musculoskeletal injuries preventing full participation
- Uncorrected visual impairment
- Use of medications affecting neuromuscular performance or coordination
- Previous or concurrent involvement in structured neuromuscular or neuro-athletic training programs
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neuro-Athletic TrainingParticipants receive a structured 8-week NAT program including oculomotor, vestibular, and proprioceptive drills, 3 sessions/week (35-45 minutes each). | Behavioural | Neuro-Athletic Training (NAT) Group |
| Standard TrainingParticipants continue their standard in-season football training program without any NAT components. | Other | Standard Training Group |
Primary outcome
Passing Accuracy (Mor-Christian Passing Test)
Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Measured as a score (max 120) based on 12 passes from 7, 8.5, and 10 meters toward a mini-goal. Assessed pre- and post-intervention.
Shooting Accuracy (Mor-Christian Shooting Test)
Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Measured as a score (max 80) based on 16 shots from 14.5 meters toward four 45 cm targets. Assessed pre- and post-intervention.
2 secondary outcomes
Flexibility (Sit-and-Reach Test)
Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks)
Isokinetic Knee Strength (ISOMED 2000 Dynamometer)
Time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Jul 2025.
- Individual participant dataSharing planned: No. Individual participant data (IPD) will not be shared due to privacy concerns and institutional data protection policies.
Related trials for Athletic Performance
Not yet recruiting
Core Strength Training, Anthropometry, and Postural Control in Youth Optimist Sailors
Postural Control, Athletic Performance
Active, not recruiting
Effects of Blood Flow Restriction Training on Physical Function, Muscle Adaptations, and Performance in Roller Skaters
Athletic Performance Enhancement
Recruiting
UCLA Magnesium Formulation Athlete Study
Athletic Performance, Recovery
Not yet recruiting
Delayed Morning Training, Sleep, and Change-of-Direction Performance in Badminton Athletes
Sleep Duration, Athletic Performance
Active, not recruitingObservational study
Physiological and Performance Characteristics of HYROX Athletes
Physical Fitness, Athletic Performance
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Neuro-Athletic Training and Standard Training in people with Athletic Performance and Neurocognitive Function, run by Ankara Yildirim Beyazıt University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Passing Accuracy (Mor-Christian Passing Test) (time frame: Pre-intervention (baseline) and post-intervention (after 8 weeks).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Jul 2025; AzTrials last refreshed its copy on 6 Nov 2026.